Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


30.12.2018

1 Am J Surg
1 Ann Oncol
2 Anticancer Res
3 BMC Cancer
2 Br J Cancer
3 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
4 Breast J
1 Cancer Lett
1 Cancer Res
1 Carcinogenesis
3 Clin Breast Cancer
1 Histopathology
1 Int J Cancer
1 J Clin Oncol
1 J Surg Oncol
1 JAMA
1 N Engl J Med
1 NPJ Breast Cancer
2 Oncol Rep
1 PLoS Biol
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. BURKHEIMER E, Starks L, Khan M, Oostendorp L, et al
    The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2018 Nov 14. pii: S0002-9610(18)30972.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. LUEN SJ, Salgado R, Dieci MV, Vingiani A, et al
    Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy.
    Ann Oncol. 2018 Dec 27. pii: 5262220. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. TAKALA L, Barlund M, Kellokumpu-Lehtinen PL, Pirkko L, et al
    Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer.
    Anticancer Res. 2019;39:279-283.
    PubMed     Text format     Abstract available

  4. ROINE E, Farkkila N, Sintonen H, Taari K, et al
    Costs in Different States of Breast Cancer.
    Anticancer Res. 2019;39:353-359.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. ZHAO J, Hu C, Wang C, Yu W, et al
    Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.
    BMC Cancer. 2018;18:1290.
    PubMed     Text format     Abstract available

  6. TAKUWA H, Tsuji W, Shintaku M, Yotsumoto F, et al
    Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
    BMC Cancer. 2018;18:1282.
    PubMed     Text format     Abstract available

  7. KUEHNEMUTH B, Piseddu I, Wiedemann GM, Lauseker M, et al
    CCL1 is a major regulatory T cell attracting factor in human breast cancer.
    BMC Cancer. 2018;18:1278.
    PubMed     Text format     Abstract available


    Br J Cancer

  8. JOHNS LE, Jones ME, Schoemaker MJ, McFadden E, et al
    Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study".
    Br J Cancer. 2018 Dec 25. pii: 10.1038/s41416-018-0344.
    PubMed     Text format    

  9. KYBA CCM, Spitschan M
    Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105000 UK women in the Generations Study'.
    Br J Cancer. 2018 Dec 25. pii: 10.1038/s41416-018-0203.
    PubMed     Text format    


    Breast Cancer (Dove Med Press)

  10. CHERNY NI, Paluch-Shimon S, Berner-Wygoda Y
    Palliative care: needs of advanced breast cancer patients.
    Breast Cancer (Dove Med Press). 2018;10:231-243.
    PubMed     Text format     Abstract available

  11. TORRES-LUQUIS O, Madden K, N'dri NM, Berg R, et al
    LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.
    Breast Cancer (Dove Med Press). 2018;11:1-12.
    PubMed     Text format     Abstract available

  12. KOEHLER LA, Haddad TC, Hunter DW, Tuttle TM, et al
    Axillary web syndrome following breast cancer surgery: symptoms, complications, and management strategies.
    Breast Cancer (Dove Med Press). 2018;11:13-19.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  13. NICKSON C, Procopio P, Velentzis LS, Carr S, et al
    Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Breast Cancer Res. 2018;20:155.
    PubMed     Text format     Abstract available


    Breast J

  14. PEDDI P, Master SR, Dwary AD, Ravipati HP, et al
    Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13182.
    PubMed     Text format     Abstract available

  15. LOH Z, Yeo B, Williams DS, Gyorki DE, et al
    Ectopic breast cancer in the inguinal region.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13177.
    PubMed     Text format    

  16. AKRAMI M, Arasteh P, Mokhtari M, Tahmasebi S, et al
    Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry.
    Breast J. 2018 Dec 27. doi: 10.1111/tbj.13183.
    PubMed     Text format    

  17. MCCORMICK B
    It is time to personalize local treatment options for women with "good risk" DCIS.
    Breast J. 2018;24:231-232.
    PubMed     Text format    


    Cancer Lett

  18. ZHANG X, Gao D, Fang K, Guo Z, et al
    Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30723.
    PubMed     Text format     Abstract available


    Cancer Res

  19. YANG F, Takagaki Y, Yoshitomi Y, Ikeda T, et al
    Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR axis.
    Cancer Res. 2018 Dec 24. pii: 0008-5472.CAN-18-0620.
    PubMed     Text format     Abstract available


    Carcinogenesis

  20. WIDATALLA SE, Korolkova OY, Whalen DS, Goodwin JS, et al
    Lapatinib induced Annexin A6 up-regulation as an adaptive response of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
    Carcinogenesis. 2018 Dec 27. pii: 5263981. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  21. GAGNO S, D'Andrea MR, Mansutti M, Zanusso C, et al
    A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
    Clin Breast Cancer. 2018 Nov 24. pii: S1526-8209(18)30679.
    PubMed     Text format     Abstract available

  22. XIPING Z, Shuai Z, Feijiang Y, Bo C, et al
    Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer.
    Clin Breast Cancer. 2018 Nov 3. pii: S1526-8209(18)30090.
    PubMed     Text format     Abstract available

  23. JACENE HA, Youn T, DiPiro PJ, Hu J, et al
    Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
    Clin Breast Cancer. 2018 Nov 26. pii: S1526-8209(18)30508.
    PubMed     Text format     Abstract available


    Histopathology

  24. KOOPMAN T, Buikema HJ, Hollema H, de Bock GH, et al
    What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Histopathology. 2018 Dec 26. doi: 10.1111/his.13812.
    PubMed     Text format     Abstract available


    Int J Cancer

  25. VAN HELLEMOND IEG, Vriens IJH, Peer PGM, Swinkels ACP, et al
    Efficacy of Anastrozole after Tamoxifen in Early Breast Cancer Patients with Chemotherapy-Induced Ovarian Function Failure.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32093.
    PubMed     Text format     Abstract available


    J Clin Oncol

  26. DELLAPASQUA S, Gray KP, Munzone E, Rubino D, et al
    Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.
    J Clin Oncol. 2018 Dec 27:JCO1800296. doi: 10.1200/JCO.18.00296.
    PubMed     Text format     Abstract available


    J Surg Oncol

  27. HELLINGMAN D, de Wit-van der Veen BJ, Wan OY, van der Ploeg IM, et al
    Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25339.
    PubMed     Text format     Abstract available


    JAMA

  28. SLOMSKI A
    Chemoimmunotherapy for Triple-Negative Breast Cancer.
    JAMA. 2018;320:2521.
    PubMed     Text format    


    N Engl J Med


  29. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2018;379:2582.
    PubMed     Text format    


    NPJ Breast Cancer

  30. DI LEO A, O'Shaughnessy J, Sledge GW Jr, Martin M, et al
    Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy.
    NPJ Breast Cancer. 2018;4:41.
    PubMed     Text format     Abstract available


    Oncol Rep

  31. SCHRODER L, Marahrens P, Koch JG, Heidegger H, et al
    Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF7 and MDA-MB-231 breast carcinoma cells.
    Oncol Rep. 2019;41:387-396.
    PubMed     Text format     Abstract available

  32. MA J, Niu W, Wang X, Zhou Y, et al
    Bromodomaincontaining protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2antagonist/killer protein.
    Oncol Rep. 2018 Dec 21. doi: 10.3892/or.2018.6951.
    PubMed     Text format     Abstract available


    PLoS Biol

  33. CHEN Y, Keskin D, Sugimoto H, Kanasaki K, et al
    Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.
    PLoS Biol. 2018;16:e2005907.
    PubMed     Text format     Abstract available


    PLoS One

  34. CHEN FP, Chien MH, Chen HY, Ng YT, et al
    Effects of phthalates on normal human breast cells co-cultured with different fibroblasts.
    PLoS One. 2018;13:e0199596.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  35. TOMINAGA K, Minato H, Murayama T, Sasahara A, et al
    Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1806851116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: